S100A12 and myocardial infarction: In this study with 10 year follow up, baseline S100A12 serum concentrations had predictive value for development of coronary artery disease, acute myocardial infarction, and cardiovascular mortality in this population-based cohort study of 839 participants without coronary heart disease at baseline.